Literature DB >> 24828904

Ocular Involvement of Behçet's Syndrome: a Comprehensive Review.

Yilmaz Ozyazgan1, Didar Ucar1, Gulen Hatemi2, Yusuf Yazici3.   

Abstract

Behçet's syndrome (BS) is a vasculitis involving several organ systems including the eyes. Ocular involvement is one of the most disabling complications of BS, causing loss of vision that may progress to blindness if left untreated. The typical form of ocular involvement is a relapsing and remitting panuveitis and retinal vasculitis. Initial attacks may spontaneously improve and subsequently disappear in a few weeks but tend to recur if left untreated. Destructive and recurrent attacks, especially with posterior segment and retina involvement, may cause irreversible ocular structural changes and permanent damage in sensory retina, resulting in loss of vision. The risk of irreversible damage to ocular tissue which may result in loss of vision warrants early and intensive treatment especially in patients at high risk such as young men who tend to follow an aggressive disease course. The management strategy involves rapid suppression of inflammation during the attacks and prevention of recurrent attacks. Local and systemic measures including immunosuppressives, corticosteroids, and biologic agents are used for this purpose. Surgery may be required in selected cases. The prognosis of eye involvement has greatly improved over the last decades with the effective use of immunosuppressives.

Entities:  

Keywords:  Behçet; Eye; Prognosis; Retinal vasculitis; Treatment; Uveitis

Mesh:

Substances:

Year:  2015        PMID: 24828904     DOI: 10.1007/s12016-014-8425-z

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  41 in total

1.  Multicenter study of infliximab for refractory uveoretinitis in Behçet disease.

Authors:  Annabelle A Okada; Hiroshi Goto; Shigeaki Ohno; Manabu Mochizuki
Journal:  Arch Ophthalmol       Date:  2012-05

2.  Regression of optic disc neovascularization in patients with Behçet's uveoretinitis after infliximab therapy.

Authors:  Tatsushi Kawaguchi; Sunao Sugita; Yukiko Yamada; Masaru Miyanaga; Manabu Mochizuki
Journal:  J Ocul Pharmacol Ther       Date:  2010-11-02       Impact factor: 2.671

3.  Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy.

Authors:  Hiroshi Keino; Annabelle A Okada; Takayo Watanabe; Wakako Taki
Journal:  Br J Ophthalmol       Date:  2010-12-22       Impact factor: 4.638

4.  Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease.

Authors:  Serdal Ugurlu; Didar Ucar; Emire Seyahi; Gulen Hatemi; Sebahattin Yurdakul
Journal:  Ann Rheum Dis       Date:  2012-05-14       Impact factor: 19.103

5.  Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.

Authors:  K Masuda; A Nakajima; A Urayama; K Nakae; M Kogure; G Inaba
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

6.  Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

Authors:  P P Sfikakis; P G Theodossiadis; C G Katsiari; P Kaklamanis; N N Markomichelakis
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

7.  Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study.

Authors:  Ahmet Gül; Ilknur Tugal-Tutkun; Charles A Dinarello; Leonid Reznikov; Bahar Artim Esen; Amer Mirza; Patrick Scannon; Alan Solinger
Journal:  Ann Rheum Dis       Date:  2011-11-14       Impact factor: 19.103

8.  Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.

Authors:  Ilknur Tugal-Tutkun; Abdulbaki Mudun; Meri Urgancioglu; Sevil Kamali; Esen Kasapoglu; Murat Inanc; Ahmet Gül
Journal:  Arthritis Rheum       Date:  2005-08

Review 9.  The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.

Authors:  S Mishima; K Masuda; Y Izawa; M Mochizuki; K Namba
Journal:  Trans Am Ophthalmol Soc       Date:  1979

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

View more
  17 in total

Review 1.  The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors:  Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

2.  Quantitative analysis of retinal microcirculation in optical coherence tomography angiography in cases with Behçet's disease without ocular involvement.

Authors:  Ayşegül Çömez; Abdullah Beyoğlu; Yalçın Karaküçük
Journal:  Int Ophthalmol       Date:  2019-03-15       Impact factor: 2.031

3.  In vivo confocal microscopy for eyes with Behçet's disease: a missing piece of the puzzle.

Authors:  Yi-Hsun Huang; Jia-Horung Hung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-09-29       Impact factor: 3.535

Review 4.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

Review 5.  Autoimmunity in 2014.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 6.  Ocular Involvement in Systemic Autoimmune Diseases.

Authors:  Elena Generali; Luca Cantarini; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 7.  Update on the treatment of Behçet's syndrome.

Authors:  Sinem Nihal Esatoglu; Gulen Hatemi
Journal:  Intern Emerg Med       Date:  2019-01-25       Impact factor: 3.397

Review 8.  A Clinical Picture of the Visual Outcome in Adamantiades-Behçet's Disease.

Authors:  Michele Figus; Chiara Posarelli; Timothy G Albert; Rosaria Talarico; Marco Nardi
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

9.  Multiple aneurysms and gastrointestinal involvement in Behcet's disease: A case report.

Authors:  Mengdi Wang; Weiwei Sun; Zhenjie Chen; Xiaona Wang; Jie Lv; Quanming Tan; Yaoxian Wang; Jingwei Zhou
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 10.  Behçet's syndrome: providing integrated care.

Authors:  Sinem Nihal Esatoglu; Zekayi Kutlubay; Didar Ucar; Ibrahim Hatemi; Ugur Uygunoglu; Aksel Siva; Gulen Hatemi
Journal:  J Multidiscip Healthc       Date:  2017-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.